Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd share price and stock overview

Astrazeneca Pharma India Ltd (NSE: ASTRAZEN, BSE: 506820) operates in the Pharmaceuticals - Multinational sector. The stock has an ISIN of INE203A01020 and a face value of Rs 2. As of 31 August 2026, it trades at Rs (6,951.50) with a market capitalisation of Rs 17765.63 crore. Figures are live and subject to change.

Astrazeneca Pharma India Ltd

Pharmaceuticals - Multinational
NSE BSE
6,951.50 -155.00 (-2.18%) downArrowC
As on: 31-Aug-2026 , 05:04 PM
Market Cap(₹Cr) 17765.63
Book Value(₹Cr) 349.116
BSE Code : 506820 NSE Symbol : ASTRAZEN EPS(TTM) : 69.39 ISIN Demat : INE203A01020 P/E(TTM) : 102.41 Face Value(₹) : 2 Div & Yield % : 0.51

Today Market

Stock Performance

Today Market

Today's High

77,177.27

Todday's Low

76,751.32

Open at

77,130.73

Previous Close

77,264.51

Volumes

Avg Price

-307.24

Historical Performance

News

25 Aug 26
AstraZeneca Pharma India Limited receives a stay on NPPA’s demand notice regarding overcharging for Betaloc-50 tablets
AstraZeneca Pharma India Limited announced that the Hon'ble High Court of Delhi has stayed the operation of a demand notice dated July 27, 2026, issued by the National Pharmaceutical Pricing Authority (NPPA) alleging overcharging for Betaloc-50 tablets, until a hearing on February 10, 2027.
04 Aug 26
AstraZeneca India to review quarterly results at a board meeting on August 10
AstraZeneca Pharma India Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing.
21 Jul 26
AstraZeneca Pharma India announces resignation of CFO
AstraZeneca Pharma India announced that Bhavana Agrawal, Executive Director and Chief Financial Officer (CFO) has resigned from the position of CFO (Key Managerial Personnel) of the company with effect from the close of business hours on 31 August 2026, pursuant to her appointment to a regional role within the AstraZeneca Group.
21 Jul 26
AstraZeneca Pharma India CFO Bhavana Agrawal resigns
The company said Agrawal stepped down following her appointment to a regional role within the AstraZeneca Group.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
28-08-26 7140.50 7170.00 7081.00 7106.50 2651 1060 18906505.00 24175.65
27-08-26 7170.00 7200.00 7070.00 7136.00 6394 2072 45635457.00 24090.85
26-08-26 7190.00 7214.00 7137.50 7153.00 3427 1144 24595604.50 24207.75
25-08-26 7264.00 7275.00 7110.00 7146.00 15334 3205 109922627.50 24334.55
24-08-26 7415.50 7474.00 7200.00 7232.00 52529 7970 381104717.00 24219.05
21-08-26 7500.00 7580.00 7371.50 7415.50 19159 4303 142369200.50 24252.00
20-08-26 7500.50 7620.00 7485.00 7507.00 9211 4024 69501794.00 24231.85
19-08-26 7680.00 7738.50 7481.00 7500.50 53650 3320 402720262.00 24078.30
18-08-26 7640.50 7759.50 7595.00 7645.00 7588 2250 58127099.50 24154.90
17-08-26 7789.50 7814.50 7602.00 7640.50 18504 2744 141453697.50 24287.65
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

17765.63

PE Ratio

102.41

PB Ratio

20.35

Dividend Yield

0.51

ROE

22.82

ROCE

27.86

Book Value (₹)

349.116

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 18750000 75.00 18750000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18750000 75.00 18750000 1
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group 18750000 75.00 18750000 1
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 670396 2.68 670396 97
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1501271 6.01 1501271 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 18341 0.07 18341 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2190383 8.76 2190258 114
plus  Non Institution
Bodies Corporate 270903 1.08 270903 261
Clearing Members 134 0.00 134 2
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 88903 0.36 88403 1059
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 83699 0.33 83698 733
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1528684 6.11 1528684 3
Individuals holding nominal share capital up to Rs. 1 lakh 1911587 7.65 1804544 27122
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 333 0.00 333 4
Others 91272 0.37 91272 1
Sub Total 4059617 16.24 3952073 29223
Total Public Shareholding 6250000 25.00 6142331 29337
Total of Promoter & Public ShareHolding 25000000 100.00 24892331 29338
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 25000000 100.00 24892331 29338

Financials (₹ in cr)

Consolidated Standalone
No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 5.005.005.005.005.005.00
Reserves Total 867.79765.35706.92583.69506.39451.17
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds872.79770.35711.92588.69511.39456.17
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 110.6635.734.597.218.6312.14
Total Debt110.6635.734.597.218.6312.14
Other Liabilities37.7515.326.218.567.506.41
Total Liabilities1021.20821.40722.72604.46527.52474.72
APPLICATION OF FUNDS :
Gross Block 184.76217.62187.13179.12168.83159.78
Less : Accumulated Depreciation 67.29153.38120.45110.2694.3478.82
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 117.4764.2466.6868.8674.4980.96
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.000.000.271.332.204.02
Producing Properties0.000.000.000.000.000.00
Investments 0.000.000.000.000.000.00
Current Assets, Loans & Advances
Inventories 1027.33548.50227.88190.21140.22159.80
Sundry Debtors 213.68184.88153.13107.5285.8985.19
Cash and Bank Balance448.62536.70505.84500.48448.46352.35
Loans and Advances 50.3072.2745.8637.2631.1021.42
Total Current Assets1739.931342.35932.71835.47705.67618.76
Less : Current Liabilities and Provisions
Current Liabilities 906.57579.55305.23336.31281.06257.44
Provisions 61.33117.1750.0844.1047.9842.55
Total Current Liabilities & Provisions967.90696.72355.31380.41329.04299.99
Net Current Assets772.03645.63577.40455.06376.63318.77
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets65.2750.5422.3122.2018.1717.31
Deferred Tax Liability27.478.981.061.531.872.78
Net Deferred Tax37.8041.5621.2520.6716.3014.53
Other Assets93.9069.9757.1258.5457.9056.44
Total Assets1021.20821.40722.72604.46527.52474.72
Contingent Liabilities121.2398.41137.64131.62121.3785.66

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -9.46-24.48-44.38-65.59-91.97
Investing Activities 4.7418.1121.7430.8018.69
Net Cash Flow 96.0851.925.2330.57-88.42
Operating Activities 100.8058.2927.8765.36-15.14

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SDN
Shilpa Divekar Nirula
Chairman & Independent Directo
Executive
Functional Directors
PRA
Praveen Rao Akkinepally
Managing Director / Business Unit Head
MD
BA
Bhavana Agrawal
Executive Director / Whole Time Director / CFO
Exec.
HBC
Hooi Bien Chuah
Non Executive Director
Exec.
Independent Directors
RA
Revathy Ashok
Independent Non Exe. Director
Ind.
MW
MONICA WIDHANI
Independent Non Exe. Director
Ind.
Other Officials
TS
Tanya Sanish
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Astrazeneca Pharma India Ltd? −

Astrazeneca Pharma India Ltd trades on NSE under ASTRAZEN and on BSE under code 506820. The ISIN is INE203A01020 and the face value is Rs 2.

What is the share price of Astrazeneca Pharma India Ltd today? +

As of 31 August 2026, Astrazeneca Pharma India Ltd trades at Rs 6,951.50, a change of -155.00 (-2.18%) on the day. Prices are live and subject to change.

What is the market capitalisation of Astrazeneca Pharma India Ltd? +

As of 31 August 2026, Astrazeneca Pharma India Ltd has a market cap of about Rs 17765.63 crore. This figure is live and moves with the share price.

Is Astrazeneca Pharma India Ltd profitable? +

In , Astrazeneca Pharma India Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Astrazeneca Pharma India Ltd? +

: As of 31 August 2026, the PE (TTM) for Astrazeneca Pharma India Ltd is 102.41 and the price-to-book ratio is 20.35. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Astrazeneca Pharma India Ltd pay a dividend? +

As of 31 August 2026, the dividend yield for Astrazeneca Pharma India Ltd is 0.51%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Astrazeneca Pharma India Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Astrazeneca Pharma India Ltd. Public shareholding is 25.00%, including mutual funds at 6.01% and foreign institutional investors at 2.68%.

What were the latest annual financials of Astrazeneca Pharma India Ltd? +

In , Astrazeneca Pharma India Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .